A Deadline is coming up on November 20, 2020 in the lawsuit for certain investors in NextCure, Inc. (NASDAQ:NXTC).
San Diego, CA -- (SBWIRE) -- 11/23/2020 -- A deadline is coming up on November 20, 2020 in the lawsuit filed for certain investors of NextCure, Inc. (NASDAQ: NXTC).
Investors who purchased shares of NextCure, Inc. (NASDAQ: NXTC) have certain options and there are strict and short deadlines running. Deadline: November 20, 2020. NASDAQ: NXTC stockholders should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of NextCure, Inc. (NASDAQ: NXTC) common shares between November 5, 2019 and July 14, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the defendants violated provisions of the Exchange and Securities Acts by misleading investors regarding its leading treatment candidate, NC318. Specifically, the complaint alleges that statements made by Defendants concerning the effectiveness of NC318, the responses observed in patients treated with NC318, and NC318's potential to treat patients' refractory to PD-1 therapies were false and misleading.
Those who purchased shares of NextCure, Inc. (NASDAQ: NXTC) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.